TY - JOUR
T1 - Placental histopathology lesions and pregnancy outcome in pregnancies complicated with symptomatic vs. non-symptomatic placenta previa
AU - Weiner, Eran
AU - Miremberg, Hadas
AU - Grinstein, Ehud
AU - Schreiber, Letizia
AU - Ginath, Shimon
AU - Bar, Jacob
AU - Kovo, Michal
N1 - Publisher Copyright:
© 2016
PY - 2016/10/1
Y1 - 2016/10/1
N2 - Background The mechanisms involved in bleeding in cases of placenta previa (PP) and the effect on pregnancy outcome is unclear. Objectives We aimed to compare pregnancy outcome and placental histopathology in pregnancies complicated with symptomatic (bleeding) vs. non-symptomatic PP, and to study the effects of the co-existence of histopathological retro-placental hemorrhage (RPH) in cases of symptomatic PP on neonatal and maternal outcomes. Study design Labor and maternal characteristics, neonatal outcome and placental histopathology lesions of pregnancies with PP, delivered between 24 and 42 weeks, during 2009–2015, were reviewed. Results were compared between PP who had elective cesarean delivery (CD) (previa group) and PP with bleeding necessitating emergent CD (symptomatic previa group). Placental lesions were classified to lesions consistent with maternal malperfusion or fetal thrombo-occlusive disease (vascular and villous changes), and inflammatory lesions. Results Compared to the previa group (n = 63), the symptomatic previa group (n = 74) was characterized by older patients (p < 0.001), higher rate of smokers (p = 0.005), thrombophilia (p = 0.038), and preterm deliveries (p < 0.001). Placentas within the symptomatic previa group were smaller, with higher rates of weight < 10th% (p = 0.02), RPH (p < 0.001) and villous changes related to maternal malperfusion (p = 0.023). As compared to symptomatic PP without RPH, co-existence of RPH was associated with higher rate of adverse neonatal outcome (p < 0.001) and maternal blood transfusion (p = 0.02). On multivariate regression analysis, composite adverse neonatal outcome was found to be dependent on coexisting RPH (OR = 2.8, 95%CI 1.2–11.7, p = 0.03), and low gestational age (OR = 3.1, 95%CI 1.6–4.9, p = 0.02). Conclusions Symptomatic placenta previa is associated with increased placental malperfusion lesions suggesting an association of maternal malperfusion with abnormal placental separation. The coexisting finding of RPH with symptomatic placenta previa can be seen as a marker for more extensive/severe placental separation, hence the association with maternal transfusion requirements and poorer fetal outcome.
AB - Background The mechanisms involved in bleeding in cases of placenta previa (PP) and the effect on pregnancy outcome is unclear. Objectives We aimed to compare pregnancy outcome and placental histopathology in pregnancies complicated with symptomatic (bleeding) vs. non-symptomatic PP, and to study the effects of the co-existence of histopathological retro-placental hemorrhage (RPH) in cases of symptomatic PP on neonatal and maternal outcomes. Study design Labor and maternal characteristics, neonatal outcome and placental histopathology lesions of pregnancies with PP, delivered between 24 and 42 weeks, during 2009–2015, were reviewed. Results were compared between PP who had elective cesarean delivery (CD) (previa group) and PP with bleeding necessitating emergent CD (symptomatic previa group). Placental lesions were classified to lesions consistent with maternal malperfusion or fetal thrombo-occlusive disease (vascular and villous changes), and inflammatory lesions. Results Compared to the previa group (n = 63), the symptomatic previa group (n = 74) was characterized by older patients (p < 0.001), higher rate of smokers (p = 0.005), thrombophilia (p = 0.038), and preterm deliveries (p < 0.001). Placentas within the symptomatic previa group were smaller, with higher rates of weight < 10th% (p = 0.02), RPH (p < 0.001) and villous changes related to maternal malperfusion (p = 0.023). As compared to symptomatic PP without RPH, co-existence of RPH was associated with higher rate of adverse neonatal outcome (p < 0.001) and maternal blood transfusion (p = 0.02). On multivariate regression analysis, composite adverse neonatal outcome was found to be dependent on coexisting RPH (OR = 2.8, 95%CI 1.2–11.7, p = 0.03), and low gestational age (OR = 3.1, 95%CI 1.6–4.9, p = 0.02). Conclusions Symptomatic placenta previa is associated with increased placental malperfusion lesions suggesting an association of maternal malperfusion with abnormal placental separation. The coexisting finding of RPH with symptomatic placenta previa can be seen as a marker for more extensive/severe placental separation, hence the association with maternal transfusion requirements and poorer fetal outcome.
KW - Hemorrhage
KW - Neonatal outcome
KW - Placenta previa
KW - Placental histopathology
KW - Placental malperfusion
KW - Retro-placental hemorrhage
UR - http://www.scopus.com/inward/record.url?scp=84986218283&partnerID=8YFLogxK
U2 - 10.1016/j.earlhumdev.2016.08.012
DO - 10.1016/j.earlhumdev.2016.08.012
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 27614329
AN - SCOPUS:84986218283
VL - 101
SP - 85
EP - 89
JO - Early Human Development
JF - Early Human Development
SN - 0378-3782
ER -